FdaApplication

ANDA 211394

Back to search

Identifiers

Properties

PropertyValue
applicant_nameYILING PHARMACEUTICAL LTD
application_typeANDA
approval_date2024-11-27

Products (4)

ProductActive ingredientStrengthDosage form
SIMVASTATINSIMVASTATIN20MGTABLET;ORAL
SIMVASTATINSIMVASTATIN80MGTABLET;ORAL
SIMVASTATINSIMVASTATIN40MGTABLET;ORAL
SIMVASTATINSIMVASTATIN10MGTABLET;ORAL

4 products